Aflac stock gains 1.37 percent as weekly high reaches EUR 102.98
Published on 10/10/2026 at 10:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Aflac stock gained 1.37 percent over the reviewed week.
- The weekly range ran from EUR 100.78 to EUR 102.98.
- Aflac published a legacy-planning study on October 6, 2026.
Aflac stock gained 1.37 percent over the reviewed week, reaching a weekly high of EUR 102.98. At 10:00 a.m. CEST on October 10, 2026, the shares were EUR 102.28 in weekend trading at Lang & Schwarz, up 0.03 percent versus the EUR 102.25 close at Lang & Schwarz on October 9, 2026.
The week in figures
The weekly close reference was EUR 102.25 at Lang & Schwarz on October 9, 2026. The reviewed range extended from EUR 100.78 to EUR 102.98, while the weekly balance was plus 1.37 percent from EUR 100.90 to EUR 102.28. Bid and ask prices at 10:00 a.m. CEST were EUR 102.05 and EUR 102.50, respectively. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CEST is shown by the continuously updated real-time quote of AFLAC Inc. stock.
Chronology of the week
On October 6, 2026, Aflac published the results of a legacy-planning study conducted among 1,000 employed U.S. adults. The company said 57 percent of respondents had a will, 50 percent had completed a power of attorney and 54 percent had advance healthcare directives in place. Aflac’s investor-relations release identified the study as a company publication.
On October 9, 2026, Keefe, Bruyette & Woods cut its price target for Aflac from USD 125.00 to USD 120.00 and maintained a market perform rating, according to MarketBeat.
Dates of the coming week
The next Xetra session is scheduled for October 12, 2026. Aflac’s next third-quarter results release is scheduled for November 4, 2026, according to the company’s investor-relations calendar cited in the weekly topic record.
Market context: Market report S&P 500.
,
